The diagnosis and treatment of hepatocellular carcinoma

As of 2008, hepatocellular carcinoma (HCC) was the 5th and 7th most common cancer in adult men and women, and the 2nd and 6th leading cause of cancer death worldwide, respectively [1]. The number of deaths worldwide, 695,900 in 2008, was nearly equal to the annual incidence of 748,300 newly diagnosed HCCs in 2008, nearly 80% of which were attributed to chronic hepatitis B and C [2]. In developing countries for instance, HBV and HCV are responsible for 60% and 33% of HCC respectively, versus 23% and 20% in developed countries [3].

Source: Seminars in Diagnostic Pathology - December 20, 2016 Category: Pathology Authors: Justin Hartke, Matthew Johnson, Marwan Ghabril Source Type: research